Exclusive Interview: Dr Jun Hu, VP, Head of XDC CEC and Singapore Site Management WuXi XDC | ADC Asia Congress 2026
As ADC programs progress into late-stage development, CMC complexity, scale-up risk, and supply reliability become increasingly critical to long-term success.
WuXi XDC’s integrated CRDMO solution and dual sourcing strategy are designed to support industry partners in navigating CMC complexity and accelerating the development and reliable delivery of safe and effective ADC therapies.
Ahead of his keynote at ADC Asia Congress on 12 March 2026, we had the opportunity to speak with Dr. Jun Hu, VP, Head of CEC and Singapore Site Management, WuXi XDC. He discusses how WuXi XDC’s integrated CRDMO solution and global dual sourcing strategy are designed to help industry partners navigate CMC challenges and accelerate the development and reliable delivery of safe and effective ADC therapies.
Download the Full White Paper Here!
Download the Full e-Book Here!
DownloadDownload the Full Interview Here!
DownloadSubscribe For News Updates
Subscribe to the IMAPAC Newsletter to stay informed of the latest news in the biopharmaceutical industry.
